Provided by Tiger Trade Technology Pte. Ltd.

Lipocine

1.93
-0.2700-12.27%
Pre-market: 1.86-0.0696-3.61%08:58 EDT
Volume:2.32M
Turnover:4.59M
Market Cap:15.91M
PE:-1.06
High:2.05
Open:2.05
Low:1.89
Close:2.20
52wk High:12.37
52wk Low:1.81
Shares:8.24M
Float Shares:6.51M
Volume Ratio:0.11
T/O Rate:35.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8181
EPS(LYR):-1.7669
ROE:-60.94%
ROA:-37.04%
PB:0.73
PE(LYR):-1.09

Loading ...

Lipocine Files Form 3 Initial Beneficial Ownership Statement for Director Michael Grissinger

Reuters
·
Aug 08

Vanda Pharmaceuticals Q2 Loss Widens on Lower Sales, Higher Costs

Reuters
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Lipocine (LPCN) and High Tide (HITI)

TIPRANKS
·
Aug 05

Lipocine Q2 2026 earnings: Missing license revenue drives top-line decline

TradingKey
·
Aug 05

Cumberland Pharmaceuticals Q2 Loss Widens After Apotex Transaction

Reuters
·
Aug 05

Niagen Bioscience Q2 Net Sales Fall, Missing Estimates

Reuters
·
Aug 05

Lipocine Q2 EPS USD -0.32

THOMSON REUTERS
·
Aug 04

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026

THOMSON REUTERS
·
Aug 04

Lipocine Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Lipocine Q2 EPS $(0.32) Beats $(0.43) Estimate, Sales $190.099K Beat $156.500K Estimate

Benzinga Earnings
·
Aug 04

Lipocine Q2 FY26 Net Loss Widens to $2.6 Million; Revenue Drops to $190,099

Reuters
·
Aug 04

Lipocine Appoints Industry Veteran Grissinger to Board

TIPRANKS
·
Aug 03

Lipocine Appoints Ex-J&J Executive Michael Grissinger to Board

Reuters
·
Aug 03

Lipocine Appoints Michael J. Grissinger to Board of Directors

THOMSON REUTERS
·
Aug 03

Lipocine Inc Expected to Post a Loss of 43 Cents a Share - Earnings Preview

Reuters
·
Jul 31

Lipocine Advances LPCN 1154 for Postpartum Depression

TIPRANKS
·
Jun 13

Lipocine Shareholders Approve Directors, Auditor and Incentive Plan

TIPRANKS
·
Jun 05

Lipocine shareholders approve sixth amendment to 2014 stock incentive plan at annual meeting

Reuters
·
Jun 05

Lipocine to host virtual KOL event on postpartum depression treatment LPCN 1154

Reuters
·
Jun 04

Lipocine posts Phase 3 LPCN 1154 postpartum depression trial presentation

Reuters
·
May 28